Pages that link to "Q35162222"
Jump to navigation
Jump to search
The following pages link to Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells (Q35162222):
Displaying 50 items.
- Silaffins in Silica Biomineralization and Biomimetic Silica Precipitation (Q26795747) (← links)
- Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility (Q28384598) (← links)
- Nanoparticles for imaging and treating brain cancer (Q28394053) (← links)
- Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside (Q31065446) (← links)
- Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles (Q33594253) (← links)
- VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system. (Q34674541) (← links)
- A reversible light-operated nanovalve on mesoporous silica nanoparticles. (Q35009134) (← links)
- Targeted fluorescent magnetic nanoparticles for imaging of human breast cancer (Q35016938) (← links)
- Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden. (Q36103833) (← links)
- Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups (Q36161045) (← links)
- Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. (Q36328315) (← links)
- Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery (Q36511906) (← links)
- Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. (Q36562731) (← links)
- Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo (Q36749553) (← links)
- Nanoparticle-dendrimer hybrid nanocapsules for therapeutic delivery (Q37013390) (← links)
- Nanoparticle mediated non-covalent drug delivery (Q37104463) (← links)
- Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery (Q37134029) (← links)
- Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition. (Q37157022) (← links)
- In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. (Q37327759) (← links)
- Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy (Q37624164) (← links)
- Smart Mesoporous Nanomaterials for Antitumor Therapy. (Q37638621) (← links)
- Mesoporous silica nanoparticles in biomedical applications (Q37973069) (← links)
- Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery (Q37989408) (← links)
- Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery (Q38002853) (← links)
- MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition (Q38154210) (← links)
- Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. (Q38271137) (← links)
- Molecular and supramolecular switches on mesoporous silica nanoparticles (Q38437008) (← links)
- Targeting Innate Immunity with dsRNA-Conjugated Mesoporous Silica Nanoparticles Promotes Antitumor Effects on Breast Cancer Cells (Q38814030) (← links)
- Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release (Q38827516) (← links)
- Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo (Q38857018) (← links)
- Biofabricated nanoparticle coating for liver-cell targeting (Q38857226) (← links)
- A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery (Q38874416) (← links)
- Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery (Q38958959) (← links)
- A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery (Q39084260) (← links)
- LHRH-PE40 fusion protein tethered silica nanorattles for imaging-guided tumor-specific drug delivery and bimodal therapy (Q39121585) (← links)
- Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells (Q39123634) (← links)
- Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy (Q39402544) (← links)
- Correlation between Membrane Partitioning and Functional Activity in a Single Lipid Vesicle Assay Establishes Design Guidelines for Antiviral Peptides (Q42174162) (← links)
- Highly luminescent and photostable core-shell dye nanoparticles for high efficiency bioimaging (Q46189126) (← links)
- Bis-clickable Mesoporous Silica Nanoparticles: Straightforward Preparation of Light-Actuated Nanomachines for Controlled Drug Delivery with Active Targeting (Q46417451) (← links)
- A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions (Q47101332) (← links)
- Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights. (Q50163907) (← links)
- Time-gated luminescence bioimaging with new luminescent nanocolloids based on [Mo6I8(C2F5COO)6]2- metal atom clusters. (Q50225092) (← links)
- Oxime ligation on the surface of mesoporous silica nanoparticles (Q50986669) (← links)
- Synthesis and in vitro PDT evaluation of new porphyrins containing meso-epoxymethylaryl cationic groups. (Q52565200) (← links)
- Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. (Q52582698) (← links)
- A designed 5-fluorouracil-based bridged silsesquioxane as an autonomous acid-triggered drug-delivery system. (Q53095105) (← links)
- Influence of surface functionalization on the hydrophilic character of mesoporous silica nanoparticles. (Q53517661) (← links)
- Gold Nanoparticles: A Powerful Tool to Visualize Proteins on Ordered Mesoporous Silica and for the Realization of Theranostic Nanobioconjugates (Q57176835) (← links)
- Ceramic Nanoparticles for Cancer Treatment (Q57341099) (← links)